Clinical Trial Update: Chondrofix Osteochondral Allograft Prospective Study [NA]

View source ↗

Summary

A clinical trial update indicates that the Chondrofix Osteochondral Allograft prospective study sponsored by Zimmer Orthobiologics, Inc. has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Articular Cartilage Degeneration
• Articular Cartilage Disorder
• Cartilage Injury
• Defect of Articular Cartilage

Drugs mentioned

• Chondrofix (osteochondral allograft)

Snippet

Sponsor: Zimmer Orthobiologics, Inc. | Conditions: Articular Cartilage Disorder, Degeneration; Articular Cartilage | NA | Status: TERMINATED